Results 1 to 10 of about 2,543,811 (344)

Epidemiology of chronic kidney disease: an update 2022

Kidney International Supplements, 2022
Chronic kidney disease is a progressive condition that affects >10% of the general population worldwide, amounting to >800 million individuals. Chronic kidney disease is more prevalent in older individuals, women, racial minorities, and in people ...
Csaba Kovesdy
exaly   +2 more sources

Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 [PDF]

The Lancet, 2020
Summary Background Health system planning requires careful assessment of chronic kidney disease (CKD) epidemiology, but data for morbidity and mortality of this disease are scarce or non-existent in many countries.
Boris Caroline A Andrew S Mari Amir Molla Oladimeji M Mo Bikbov Purcell Levey Smith Abdoli Abebe Adebayo Af, B. Bikbov, Caroline A. Purcell, A. Levey, Mari Smith, Amir Abdoli, Molla Abebe, O. Adebayo, M. Afarideh, Sachin Agarwal, Marcela Agudelo-Botero, E. Ahmadian, Z. Al-Aly, V. Alipour, A. Almasi-Hashiani, R. Al-Raddadi, N. Alvis-Guzmán, S. Amini, Tudorel Andrei, C. Andrei, Zewudu Andualem, Mina Anjomshoa, J. Arabloo, A. Ashagre, Daniel Asmelash, Z. Ataro, M. Atout, M. Ayanore, A. Badawi, A. Bakhtiari, S. Ballew, A. Balouchi, Maciej Banach, S. Barquera, S. Basu, Mulat Tirfie Bayih, Neeraj Bedi, A. Bello, I. Benseñor, Ali Bijani, A. Boloor, A. Borzì, L. Cámera, J. Carrero, F. Carvalho, Franz Castro, F. Catalá-López, Alex R. Chang, K. Chin, S. Chung, Massimo Cirillo, Ewerton Cousin, L. Dandona, R. Dandona, A. Daryani, R. Das Gupta, F. M. Demeke, Gebre Teklemariam Demoz, Desilu Mahari Desta, H. Do, B. Duncan, A. Eftekhari, A. Esteghamati, S. S. Fatima, João Fernandes, E. Fernandes, F. Fischer, M. Freitas, M. Gad, Gebreamlak Gebremedhn Gebremeskel, B. M. Gebresillassie, Birhanu Geta, M. Ghafourifard, A. Ghajar, N. Ghith, P. Gill, I. Ginawi, R. Gupta, N. Hafezi-Nejad, A. Haj-Mirzaian, A. Haj-Mirzaian, Ninuk Hariyani, M. Hasan, Milad Hasankhani, A. Hasanzadeh, H. Y. Hassen, Simon Iain Hay, B. Heidari, C. Herteliu, C. L. Hoang, M. Hosseini, M. Hostiuc, S. Irvani, S. Islam, Nader Jafari Balalami, S. James, S. Jassal, V. Jha, J. Jonas, F. Joukar, J. Jozwiak, Alia Kabir, Amaha Kahsay, A. Kasaeian, T. Kassa, Hagazi Gebremedhin Kassaye, Yousef S. Khader, Rovshan Khalilov, E. Khan, M. S. Khan, Y. Khang, A. Kisa, C. Kovesdy, Barthelemy Kuate Defo, G. Kumar, A. Larsson, L. Lim, Alan D. Lopez, P. Lotufo, A. Majeed, R. Malekzadeh, Winfried März, Anthony Masaka, H. Meheretu, T. Miazgowski, Andreea Mirica, E. Mirrakhimov, P. Mithra, B. Moazen, D. K. Mohammad, R. Mohammadpourhodki, S. Mohammed, A. Mokdad, Linda Morales, Ilais Moreno Velásquez, Seyyed Meysam Mousavi, S. Mukhopadhyay, J. Nachega, Girish N. Nadkarni, J. R. Nansseu, G. Natarajan, Javad Nazari, B. Neal, R. Negoi, C. Nguyen, Rajan Nikbakhsh, J. Noubiap, C. Nowak, A. Olagunju, Alberto Ortiz, M. Owolabi, R. Palladino, M. Pathak, H. Poustchi, S. Prakash, N. Prasad, A. Rafiei, S. Raju, K. Ramezanzadeh, S. Rawaf, D. Rawaf, Lal B Rawal, R. Reiner, A. Rezapour, Daniel Ribeiro, Leonardo Roever, D. Rothenbacher, G. M. Rwegerera, S. Saadatagah, Saeed Safari, B. Sahle, Hosni Salem, J. Sanabria, I. Santos, Arash Sarveazad, M. Sawhney, E. Schaeffner, M. Schmidt, A. Schutte, S. Sepanlou, M. Shaikh, Z. Sharafi, M. Sharif, Amrollah Sharifi, D. Silva, Jasvinder A. Singh, N. Singh, M. M. Sisay, A. Soheili, I. Sutradhar, B. Teklehaimanot, B. Tesfay, Getnet Teshome, J. Thakur, M. Tonelli, Khanh B. Tran, B. Tran, Candide Tran Ngoc, I. Ullah, Pascual Valdez, S. Varughese, Theo Vos, L. G. Vu, Yasir Waheed, A. Werdecker, H. F. Wolde, A. Wondmieneh, Sarah Wulf Hanson, Tomohide Yamada, Yigizie Yeshaw, N. Yonemoto, H. Yusefzadeh, Z. Zaidi, Leila Zaki, S. Zaman, N. Zamora, A. Zarghi, Kaleab Alemayehu Zewdie, J. Ärnlöv, J. Coresh, N. Perico, G. Remuzzi, C. Murray, Theo Vos   +223 more
semanticscholar   +8 more sources

Dapagliflozin in Patients with Chronic Kidney Disease

New England Journal of Medicine, 2020
BACKGROUND Patients with chronic kidney disease have a high risk of adverse kidney and cardiovascular outcomes. The effect of dapagliflozin in patients with chronic kidney disease, with or without type 2 diabetes, is not known.
Bergur Stefansson, Peter Rossing, Tom Greene   +2 more
exaly   +2 more sources

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes

New England Journal of Medicine, 2020
BACKGROUND Finerenone, a nonsteroidal, selective mineralocorticoid receptor antagonist, reduced albuminuria in short-term trials involving patients with chronic kidney disease (CKD) and type 2 diabetes.
Bertram Pitt, Luis M Ruilope, Rajiv Agarwal   +2 more
exaly   +2 more sources

Acute Kidney Injury and Chronic Kidney Disease as Interconnected Syndromes

New England Journal of Medicine, 2014
For more than 40 years, nephrologists have classified diminished kidney function as two distinct syndromes — acute and chronic kidney failure. Whereas chronic kidney disease was recognized in the 19th century, acute renal dysfunction became evident ...
Lakhmir Chawla, Chawla Lakhmir S, Star Robert A   +2 more
exaly   +2 more sources

Identification of factors associated with high-cost use of inpatient care in chronic kidney disease: a registry study

BMJ Open, 2021
Objective To explore factors behind inpatient admissions by high-cost users (HCUs) in pre-end-stage chronic kidney disease (CKD).Design Retrospective analysis of CKD.QLD Registry and hospital admissions of the Queensland Government Department of Health ...
P. Marcin Sowa, Sree K. Venuthurupalli, Wendy E. Hoy, Jianzhen Zhang, Anne Cameron, Helen G. Healy, Luke B. Connelly   +6 more
doaj   +1 more source

Ensuring Indigenous co-leadership in health research: a Can-SOLVE CKD case example

International Journal for Equity in Health, 2023
Background Indigenous people are insightful and informed about their own health and wellness, yet their visions, strengths and knowledge are rarely incorporated into health research.
Cathy Woods, Craig Settee, Mary Beaucage, Helen Robinson-Settee, Arlene Desjarlais, Evan Adams, Catherine Turner, Malcolm King, Letitia Pokiak, Mary Wilson, Evelyn Voyageur, Chantel Large, Jonathan McGavock, Joanne Kappel, Helen Chiu, Tamara Beardy, Isabelle Flett, James Scholey, Heather Harris, Jocelyn Jones, Latash Maurice Nahanee, Delhia Nahanee, on behalf of the Can-SOLVE CKD Indigenous Peoples’ Engagement, Research Council (IPERC)   +22 more
doaj   +1 more source

Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)

Diabetes Care, 2022
People with diabetes and chronic kidney disease (CKD) are at high risk for kidney failure, atherosclerotic cardiovascular disease, heart failure, and premature mortality. Recent clinical trials support new approaches to treat diabetes and CKD.
I. D. de Boer, K. Khunti, Tami Sadusky, K. Tuttle, J. Neumiller, Connie M. Rhee, Sylvia E. Rosas, P. Rossing, G. Bakris   +8 more
semanticscholar   +2 more sources

Effect of cardiac function in patients with gastrointestinal cancer with or without acute kidney injury assessed using a non-invasive impedance cardiography: a case-control study

BMC Cardiovascular Disorders, 2023
Objectives This study aimed to analyze the possible causes of changes in cardiac function and investigate the feasibility of clinical assessment of gastrointestinal cancer in patients with or without acute kidney injury (AKI) assessed using a non ...
Huihui Chen, Guolei Zhang, Lei He, Wei Zhou, Shenglei Zhang, Zhe zhe Niu, Jingjing Jin, Mei juan Cheng, Liping Guo, Xiang nan Liang, Rong fang Zhu, Huiran Zhang, Yaling Bai, Jin sheng Xu   +13 more
doaj   +1 more source

Empagliflozin in Patients with Chronic Kidney Disease

New England Journal of Medicine, 2022
Background This study, the EMPA-KIDNEY trial, was designed to assess the effects of empagliflozin in a broad range of patients with chronic kidney disease (CKD) at risk of progression. Methods We randomly assigned 6609 participants to empagliflozin (10mg
W. Herrington, N. Staplin, C. Wanner, J. B. Green, S. Hauske, J. Emberson, D. Preiss, P. Judge, Kaitlin J. Mayne, S. Ng, E. Sammons, D. Zhu, M. Hill, W. Stevens, K. Wallendszus, S. Brenner, A. Cheung, Zhi-Hong Liu, Jing Li, L. Hooi, W. Liu, T. Kadowaki, M. Nangaku, A. Levin, D. Cherney, A. Maggioni, R. Pontremoli, R. Deo, S. Goto, X. Rosselló, Katherine R. Tuttle, D. Steubl, M. Petrini, D. Massey, Jens Eilbracht, M. Brueckmann, M. Landray, C. Baigent, R. Haynes   +38 more
semanticscholar   +1 more source